• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deal search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
      • Deals search
      • Exits search
      • Funds search
      • Sponsors search
      • Advisers search
      • LPs search
      • League tables
      • Reports
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
UNQUOTE
  • Funds

Dutch VC NLC Health aims to raise a further EUR 80m for fourth fund

  • Anastasia Gnezditskaia
  • 17 July 2023
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

Dutch venture capital (VC) firm NLC Health is seeking to raise a further EUR 80m for its fourth fund by June 2024 to reach a final close, investment director Hidde Ten Brink told Mergermarket.

The VC's co-investment vehicle reached a first close of EUR 20m earlier this year, and has already started investing, he said. With a target of EUR 100m, it welcomes private investors, institutional investors such as pension funds and insurance companies, as well as family offices and impact investors.

The fourth fund will be substantially larger than the third one, which received commitments of EUR 10.8m. It accepts LP commitments of EUR 100,000-EUR 5m, Ten Brink said.

NLC Health invests solely in companies that were built by NLC's venture builder, which currently has 81 companies in its portfolio. The venture builder was set up in 2015 with the goal of supporting companies at a stage that precedes the venture capital stage, he said. It finances companies starting from the proof-of-concept and pre-seed stages, but also including those conducting clinical trials, but always pre-revenue companies, Ten Brink noted.

The companies in the NLC universe are primarily medtech, but also biotech and digital tech, with a special focus on green health supporting ventures that help dispose of medical waste, the executive said. It is an impact-driven certified B corporation, he added.

It finances companies in the EU and the US, and tends to hold investments for 10 years. It tackles risk by diversifying investments across around 80 ventures, and this number could reach 90, he said.

With this dedicated deal flow, NLC Health co-invests alongside external investors providing tickets of up to EUR 5m. Among the earliest investments in the portfolio are Dutch health tech company Nico-lab, which has developed software to diagnose and treat strokes; and Bilihome, a Dutch company that provides jaundice treatment for newborns.

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Funds
  • Venture
  • Healthcare
  • Technology
  • Benelux
  • Exclusive
  • Venture
  • Netherlands

More on Funds

Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • Funds
  • 05 September 2023
Change Ventures aims to hold final close for EUR 20m third fund by mid-2024
Change Ventures aims to hold final close for EUR 20m third fund by mid-2024

Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds

  • Funds
  • 31 August 2023
Iron Wolf Capital targets EUR 70m for second vehicle
Iron Wolf Capital targets EUR 70m for second vehicle

Baltic investor anticipates early 2024 launch and will focus on early-stage AI and deeptech startups

  • Funds
  • 30 August 2023
Siena aims to hold new VC secondaries fund first close in late 2023 or early 2024
Siena aims to hold new VC secondaries fund first close in late 2023 or early 2024

Secondary investments specialist will target EUR 30m to EUR 50m for new fund

  • Funds
  • 29 August 2023

Latest News

Partners Group to release IMs for Civica sale in mid-September
  • Exits
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
BHM Group builds on PE strategy, eyes European medtech and renewable energy acquisitions
  • Investments
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Czech Republic-headquartered family office is targeting DACH and CEE region deals

  • 01 September 2023
Redalpine expands leadership team amid CHF 1bn-plus fundraise
  • Venture
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO

  • 31 August 2023
Change Ventures aims to hold final close for EUR 20m third fund by mid-2024
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds

  • 31 August 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013